Skip to main content
Cachet Pharmaceutical Co., Ltd. logo

Cachet Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 002462 ISIN · CNE100000SN0 LEI · 300300CBONJS7HUOCX64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,441 across all filing types
Latest filing 2010-10-20 Interim / Quarterly Rep…
Country CN China
Listing Shenzhen Stock Exchange 002462

About Cachet Pharmaceutical Co., Ltd.

https://www.cachet.com.cn

Cachet Pharmaceutical Co., Ltd. specializes in the distribution and retail of pharmaceutical products and medical devices. The company operates an extensive wholesale network and a chain of retail pharmacies, providing comprehensive supply chain solutions to healthcare institutions and end-consumers. Its core operations include the procurement, storage, and logistics of western medicines, traditional Chinese medicines, and high-value medical consumables. Cachet Pharmaceutical emphasizes modern logistics management and professional pharmaceutical services, leveraging a robust distribution infrastructure to ensure the efficient delivery of healthcare products. The company also focuses on hospital supply chain integration and community-based retail services to enhance healthcare accessibility.

Recent filings

Filing Released Lang Actions
2010年第三季度报告正文
Interim / Quarterly Report Classification · 100% confidence The document is titled "嘉事堂药业股份有限公司 2010 年第三季度季度报告正文" which translates to "Jia Shi Tang Pharmaceutical Co., Ltd. 2010 Third Quarter Quarterly Report." It contains detailed financial data including total assets, equity, revenue, net profit, cash flow, earnings per share, and other financial indicators for the third quarter of 2010. The document also includes explanations of significant changes in financial statement items, shareholder information, and management commitments. The presence of comprehensive financial statements and analysis for a period shorter than a full fiscal year (quarterly) confirms this is an Interim / Quarterly Report. The document length is substantial (15,000 characters), and it contains actual financial data, not just an announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR). 9M 2010
2010-10-20 Chinese
关于完成工商变更登记的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the completion of industrial and commercial registration changes for the company 嘉事堂药业股份有限公司. It details changes in registered capital, company type, and business scope. The document is short (850 characters) and serves as a formal public notice of these changes rather than a detailed financial report or management discussion. It does not contain financial statements, audit information, or detailed management commentary. It is not a report itself but an announcement of a corporate change. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2010-10-11 Chinese
2010年第一次临时股东大会的法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the convening, procedures, and resolutions of a 2010 first extraordinary general meeting (临时股东大会) of 嘉事堂药业股份有限公司. It details the legality and compliance of the meeting's call, attendance, voting procedures, and results. The document does not contain financial statements or management discussion but focuses on legal compliance and validation of shareholder meeting procedures and resolutions. It is not an announcement of voting results but a legal opinion on the meeting's conduct and resolutions. This type of document is best classified under Regulatory Filings (RNS) as it is a legal compliance document related to corporate governance and shareholder meetings but does not fit into more specific categories like AGM Information or Declaration of Voting Results. The document length is 3407 characters, which is relatively short and focused on legal opinion rather than full meeting materials or voting results announcements.
2010-09-28 Chinese
2010年第一次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled as a resolution announcement from the 2010 first extraordinary shareholders' meeting of 嘉事堂药业股份有限公司. It details the meeting's convening, attendance, agenda items, voting results, and legal opinions confirming the meeting's legality and validity. The content focuses on the official results of shareholder votes on various proposals during the meeting. There is no financial data, earnings information, or report publication mentioned. The document is not a full report but an official announcement of voting results from a shareholders' meeting, fitting the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is short (1404 characters), consistent with a voting results announcement rather than a full report.
2010-09-28 Chinese
关于召开2010年第一次临时股东大会的公告
Proxy Solicitation & Information Statement Classification · 95% confidence The document is an announcement regarding the convening of the 2010 first extraordinary general meeting of shareholders for 嘉事堂药业股份有限公司. It details the meeting date, location, agenda items including proposals for the use of raised funds, amendments to company articles, and registration procedures for shareholders. The document does not contain financial statements or detailed financial analysis but serves to notify shareholders about the meeting and its agenda. This fits the definition of a Proxy Solicitation & Information Statement (PSI), as it provides information to shareholders to prepare for voting at the meeting.
2010-09-09 Chinese
关于使用部分超募资金偿还银行贷款及补充公司流动资金的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by 嘉事堂药业股份有限公司 regarding the use of part of the over-raised funds from a previous public stock issuance. It details the plan to use excess funds to repay bank loans and supplement working capital. The text references regulatory approvals, specific amounts of funds raised, and compliance with stock exchange rules and fundraising management regulations. It includes opinions from the board, supervisory committee, independent directors, and the sponsoring institution. The document is a formal announcement about the use of capital raised, specifically addressing the use of excess funds from a share issuance. It does not contain financial statements or detailed financial performance data, nor is it a full report. It is an update on capital usage and financing activities related to fundraising proceeds. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is under 5,000 characters, but it is not merely announcing the publication of a report; it provides substantive information about the use of funds.
2010-09-09 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.